PTCT
PTC Therapeutics, Inc. · Healthcare · Biotechnology
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +8 | 58.79M | $4.78B | +13 | −5 |
| Q1 2026 | 110 | -8 | 65.31M | $4.45B | +9 | −18 |
| Q4 2025 | 117 | 0 | 67.93M | $5.16B | +1 | — |
| Q3 2025 | 22 | +2 | 38.04M | $2.33B | +2 | — |
| Q2 2025 | 17 | 0 | 34.63M | $1.69B | +1 | −1 |
| Q1 2025 | 14 | +2 | 16.93M | $862.87M | +2 | — |
| Q4 2024 | 12 | 0 | 14.84M | $670.12M | — | — |
| Q3 2024 | 11 | -2 | 14.00M | $519.42M | — | −2 |
| Q2 2024 | 13 | — | 14.28M | $436.54M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.21M | — | $251.02M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 1.79M | — | $54.68M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasif) | 1.79M | — | $54.68M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 1.36M | — | $41.52M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.36M | — | $41.52M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 1.36M | — | $41.52M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 818.10K | — | $25.02M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 606.68K | — | $18.55M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 606.68K | — | $18.55M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 318.17K | — | $9.73M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Millennium Management ✦ | 317.58K | — | $9.71M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 300.00K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 270.08K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 270.08K | — | $8.26M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 179.68K | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 179.68K | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 68.91K | — | $2.11M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 68.91K | — | $2.11M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 68.91K | — | $2.11M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 26.70K | — | $816,486 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Norges Bank ✦ (pasif) | 15.10K | — | $461,758 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 4.16M saham, $5.53M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 2.39K lbr · $171,793
Director · 691 lbr · $50,388
Director · 9.42K lbr · $666,677
Director · 7.17K lbr · $527,846
Director · 5.33K lbr · $388,708
Officer · 969 lbr · $70,640
Officer · 1.84K lbr · $133,487
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi